Research ExplorerJournalsHYPERTENS RES Publications

HYPERTENS RES - HYPERTENSION RESEARCH

1 - 4 out of 4Page size: 50

Publications

  1. 2022

  2. Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension

    Grabowski, K., Herlan, L., Witten, A., Qadri, F., Eisenreich, A., Lindner, D., Schädlich, M., Schulz, A., Subrova, J., Mhatre, K. N., Primessnig, U., Plehm, R., van Linthout, S., Escher, F., Bader, M., Stoll, M., Westermann, D., Heinzel, F. R. & Kreutz, R., 02.2022, In: HYPERTENS RES. 45, 2, p. 292-307 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2021

  4. Urinary albumin-to-creatinine ratio is inversely related to nitric oxide synthesis in young black adults: the African-PREDICT study

    Craig, A., Mels, C. M. C., Schutte, A. E., Bollenbach, A., Tsikas, D., Schwedhelm, E. & Kruger, R., 01.2021, In: HYPERTENS RES. 44, 1, p. 71-79 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2019

  6. Dronedarone induces regression of coronary artery remodeling related to better global antioxidant status

    Quintana-Villamandos, B., Pazó-Sayós, L., Arribas, S. M., Rodríguez-Rodríguez, P., Böger, R. H., Lüneburg, N., Delgado-Baeza, E. & González, M. C., 10.2019, In: HYPERTENS RES. 42, 10, p. 1485-1494 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2016

  8. Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats

    Quintana-Villamandos, B., Arnalich-Montiel, A., Arribas, S., Lüneburg, N., Böger, R. H., Delgado-Martos, M. J., Fernández-Criado, C., Delgado-Baeza, E. & González, M. C., 10.2016, In: HYPERTENS RES. 39, 10, p. 692-700 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review